ALS and Motor Neuron Diseases
EMG findings, respiratory management, and El Escorial criteria for ALS.
Awaji-Shima & Revised El Escorial Criteria
Diagnosis requires evidence of lower motor neuron (LMN) and upper motor neuron (UMN) degeneration, progressive spread of symptoms, and absence of alternative disease processes.
Electromyography (EMG) Findings
Key findings supporting LMN involvement include active denervation (fibrillation potentials, positive sharp waves) and chronic reinnervation (large amplitude, long duration motor unit action potentials) across multiple body segments.
Common Clinical Mistakes
- Premature anchoring on common diagnoses without evaluating red flags.
- Over-reliance on neuroimaging while neglecting detailed physical exams.
- Suboptimal dosing of first-line agents before declaring treatment failure.
Frequently Asked Questions
- When is immediate specialist referral required?
- Urgent referral is indicated for sudden onset of severe symptoms, rapidly progressive deficits, or when standard therapies fail.
- What are the primary outcome measures in recent clinical trials?
- Most contemporary trials focus on slowing disease progression (e.g., EDSS in MS, UPDRS in Parkinson's) and reducing relapse/event rates.
- How does this condition impact patient life expectancy?
- While highly variable, modern disease-modifying therapies have significantly improved long-term survival rates across neurodegenerative and neuroimmunological disorders.